Aggregation and Fibril Structure of AβM01–42 and Aβ1–42
- Robert Silvers
- ,
- Michael T. Colvin
- ,
- Kendra K. Frederick
- ,
- Angela C. Jacavone
- ,
- Susan Lindquist
- ,
- Sara Linse
- , and
- Robert G. Griffin
Abstract

A mechanistic understanding of Aβ aggregation and high-resolution structures of Aβ fibrils and oligomers are vital to elucidating relevant details of neurodegeneration in Alzheimer’s disease, which will facilitate the rational design of diagnostic and therapeutic protocols. The most detailed and reproducible insights into structure and kinetics have been achieved using Aβ peptides produced by recombinant expression, which results in an additional methionine at the N-terminus. While the length of the C-terminus is well established to have a profound impact on the peptide’s aggregation propensity, structure, and neurotoxicity, the impact of the N-terminal methionine on the aggregation pathways and structure is unclear. For this reason, we have developed a protocol to produce recombinant Aβ1–42, sans the N-terminal methionine, using an N-terminal small ubiquitin-like modifier–Aβ1–42 fusion protein in reasonable yield, with which we compared aggregation kinetics with AβM01–42 containing the additional methionine residue. The data revealed that Aβ1–42 and AβM01–42 aggregate with similar rates and by the same mechanism, in which the generation of new aggregates is dominated by secondary nucleation of monomers on the surface of fibrils. We also recorded magic angle spinning nuclear magnetic resonance spectra that demonstrated that excellent spectral resolution is maintained with both AβM01–42 and Aβ1–42 and that the chemical shifts are virtually identical in dipolar recoupling experiments that provide information about rigid residues. Collectively, these results indicate that the structure of the fibril core is unaffected by N-terminal methionine. This is consistent with the recent structures of AβM01–42 in which M0 is located at the terminus of a disordered 14-amino acid N-terminal tail.
Cited By
This article is cited by 18 publications.
- Alexander I. P. Taylor, Peter J. Davis, Liam D. Aubrey, Joshua B. R. White, Zoe N. Parton, Rosemary A. Staniforth. Simple, Reliable Protocol for High-Yield Solubilization of Seedless Amyloid-β Monomer. ACS Chemical Neuroscience 2023, 14
(1)
, 53-71. https://doi.org/10.1021/acschemneuro.2c00411
- Sheng Zhang, Stan Yoo, Dalton T. Snyder, Benjamin B. Katz, Amy Henrickson, Borries Demeler, Vicki H. Wysocki, Adam G. Kreutzer, James S. Nowick. A Disulfide-Stabilized Aβ that Forms Dimers but Does Not Form Fibrils. Biochemistry 2022, 61
(4)
, 252-264. https://doi.org/10.1021/acs.biochem.1c00739
- Tinna Pálmadóttir, Anders Malmendal, Thom Leiding, Mikael Lund, Sara Linse. Charge Regulation during Amyloid Formation of α-Synuclein. Journal of the American Chemical Society 2021, 143
(20)
, 7777-7791. https://doi.org/10.1021/jacs.1c01925
- Longgang Jia, Wenjuan Wang, Jingcheng Sang, Wei Wei, Wenping Zhao, Fuping Lu, Fufeng Liu. Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His6-Tagged Aβ1–42. ACS Chemical Neuroscience 2019, 10
(3)
, 1251-1262. https://doi.org/10.1021/acschemneuro.8b00333
- Stan Yoo, Sheng Zhang, Adam G. Kreutzer, James S. Nowick. An Efficient Method for the Expression and Purification of Aβ(M1–42). Biochemistry 2018, 57
(26)
, 3861-3866. https://doi.org/10.1021/acs.biochem.8b00393
- Gabriel A. Braun, Alexander J. Dear, Kalyani Sanagavarapu, Henrik Zetterberg, Sara Linse. Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation. Chemical Science 2022, 13
(8)
, 2423-2439. https://doi.org/10.1039/D1SC02990H
- Salima Bahri, Robert Silvers, Brian Michael, Kristaps Jaudzems, Daniela Lalli, Gilles Casano, Olivier Ouari, Anne Lesage, Guido Pintacuda, Sara Linse, Robert G. Griffin. 1
H detection and dynamic nuclear polarization–enhanced NMR of Aβ
1-42
fibrils. Proceedings of the National Academy of Sciences 2022, 119
(1)
https://doi.org/10.1073/pnas.2114413119
- Veronica Lattanzi, Katja Bernfur, Emma Sparr, Ulf Olsson, Sara Linse. Solubility of Aβ40 peptide. JCIS Open 2021, 4 , 100024. https://doi.org/10.1016/j.jciso.2021.100024
- Rodrigo Cataldi, Sean Chia, Katarina Pisani, Francesco S. Ruggeri, Catherine K. Xu, Tomas Šneideris, Michele Perni, Sunehera Sarwat, Priyanka Joshi, Janet R. Kumita, Sara Linse, Johnny Habchi, Tuomas P. J. Knowles, Benedetta Mannini, Christopher M. Dobson, Michele Vendruscolo. A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers. Communications Biology 2021, 4
(1)
https://doi.org/10.1038/s42003-020-01490-3
- Anna S. König, Nadine S. Rösener, Lothar Gremer, Markus Tusche, Daniel Flender, Elke Reinartz, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold, Henrike Heise. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. Journal of Biological Chemistry 2021, 296 , 100499. https://doi.org/10.1016/j.jbc.2021.100499
- Dev Thacker, Kalyani Sanagavarapu, Birgitta Frohm, Georg Meisl, Tuomas P. J. Knowles, Sara Linse. The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils. Proceedings of the National Academy of Sciences 2020, 117
(41)
, 25272-25283. https://doi.org/10.1073/pnas.2002956117
- Longgang Jia, Wenping Zhao, Wei Wei, Xiao Guo, Wenjuan Wang, Ying Wang, Jingcheng Sang, Fuping Lu, Fufeng Liu. Expression and purification of amyloid β-protein, tau, and α-synuclein in
Escherichia coli
: a review. Critical Reviews in Biotechnology 2020, 40
(4)
, 475-489. https://doi.org/10.1080/07388551.2020.1742646
- Longgang Jia, Ying Wang, Wei Wei, Wenping Zhao, Fuping Lu, Fufeng Liu. Vitamin B12 inhibits α-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity. Food & Function 2019, 10
(5)
, 2861-2870. https://doi.org/10.1039/C8FO02471E
- Matthew G. Iadanza, Robert Silvers, Joshua Boardman, Hugh I. Smith, Theodoros K. Karamanos, Galia T. Debelouchina, Yongchao Su, Robert G. Griffin, Neil A. Ranson, Sheena E. Radford. The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Nature Communications 2018, 9
(1)
https://doi.org/10.1038/s41467-018-06761-6
- Matthew G. Iadanza, Matthew P. Jackson, Eric W. Hewitt, Neil A. Ranson, Sheena E. Radford. A new era for understanding amyloid structures and disease. Nature Reviews Molecular Cell Biology 2018, 19
(12)
, 755-773. https://doi.org/10.1038/s41580-018-0060-8
- Yanpeng Zheng, Lingwan Xu, Jingfa Yang, Xianglei Peng, He Wang, Na Yu, Ying Hua, Jiang Zhao, Jinsheng He, Tao Hong. The effects of fluorescent labels on Aβ
42
aggregation detected by fluorescence correlation spectroscopy. Biopolymers 2018, 109
(11)
https://doi.org/10.1002/bip.23237
- Jessica D. Flynn, Jennifer C. Lee. Raman fingerprints of amyloid structures. Chemical Communications 2018, 54
(51)
, 6983-6986. https://doi.org/10.1039/C8CC03217C
- Laurence J. Young, Gabriele S. Kaminski Schierle, Clemens F. Kaminski. Imaging Aβ(1–42) fibril elongation reveals strongly polarised growth and growth incompetent states. Phys. Chem. Chem. Phys. 2017, 19
(41)
, 27987-27996. https://doi.org/10.1039/C7CP03412A